Duales Studium 2026: Bachelor of Engineering Maschinenbau (m/w/d) at Clairo

Hanover, Lower-Saxony, Germany

Clairo Logo
Not SpecifiedCompensation
Internship, Entry Level & New GradExperience Level
Full TimeJob Type
UnknownVisa
Automotive, Battery TechnologyIndustries

Requirements

  • Allgemeine oder fachgebundene Hochschulreife (Abitur)
  • Gute bis sehr gute Leistungen in Mathematik, Deutsch und Englisch sowie in betriebswirtschaftlichen und technischen Fächern
  • Sehr gute sprachliche Ausdrucksfähigkeit
  • Interesse an wirtschaftlichen Zusammenhängen
  • Motivation, Engagement und Eigeninitiative
  • Team-, Kommunikations- und Problemlösungsfähigkeit
  • Selbstständige Arbeitsweise
  • Engagierte und zielstrebige Abiturienten (m/w/d) für Start August 2026 am Standort Hannover

Responsibilities

  • Technische Ausbildung mit IHK-Abschluss (Mechatroniker) im 1. Studienabschnitt
  • Vollzeitstudium im 2. Studienabschnitt mit Theorie- und Praxisphasen
  • Theoriephasen an der Hochschule Hannover
  • Praxisphasen in den entsprechenden Abteilungen (PT - Produktionstechnik, KT - Konstruktionstechnik, WT - Wirtschaftsingenieurwesen)
  • Aktive Mitarbeit im Tagesgeschäft (z. B. Wartung, Reparatur, Instandhalten von Maschinen und Anlagen; Fertigung, Programmierung und Einbau von Maschinenbauteilen)
  • Selbständige Bearbeitung von Projekten
  • Abschluss mit Bachelor of Engineering (B.Eng.)
  • Teilnahme an Seminaren, Schulungen und spannenden Projekten

Skills

Key technologies and capabilities for this role

MechatronicsMechanical EngineeringProduction TechnologyDesign TechnologyIndustrial EngineeringMachine MaintenanceRepairManufacturingProgrammingInstallation

Questions & Answers

Common questions about this position

What qualifications are required for the dual study program?

Candidates need general or subject-specific university entrance qualifications (Abitur), good to very good grades in Mathematics, German, and English, plus interest in business contexts, motivation, and strong team, communication, and problem-solving skills.

What is the structure of the dual study program?

The 3.5-year program includes technical training with IHK certification as Mechatroniker in the first section, full-time study with theory at Hochschule Hannover and practice phases in company departments in the second section, active work in daily operations, and projects, ending with a Bachelor of Engineering.

Is there a salary or compensation mentioned for this dual study position?

This information is not specified in the job description.

What benefits does the program offer?

The company covers all tuition fees, provides seminars, training, exciting projects, a possible overseas stay, and with good performance, takeover into permanent employment after completion.

What is the location and work arrangement for the program?

The program is at the Hannover site, starting August 2026, with theory phases at Hochschule Hannover and practice phases in company departments, combining full-time study and practical work.

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters
1972Year Founded
$29.9MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Competitive and equitable total rewards package
Physical, mental and financial health and wellness
Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.
The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.
AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.
The company has nearly 50 years of experience in clinical trial technology solutions.
Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.
The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.
Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI